Association of serum and sputum resistin like molecule-beta(RELM-beta) with airway remodeling in bronchial asthma

Not Applicable

• Conditions: bronchial asthma

• Registration Number: JPRN-UMIN000020412
• Lead Sponsor: agoya City University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-12-31
• Study Completion: 2017-03-18
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

If patients meet the following criteria, they are excluded. Patients who i. have respiratory tract infection or other respiratory disease within 4 weeks prior to enrollment ii. have asthma attacks within 4 weeks prior to enrollment iii. use anti-allergy drugs or inhaled anticholinergic drugs within 2 weeks prior to enrollment iv. use systemic corticosteroids within 4 weeks prior to enrollment v. currently smoke, had smoking history with 5 pack-years or more, or had quitted smoking within 6 months prior to the enrollment vi. prepare for pregnancy, in pregnancy or breast-feeding vii. unsuitable for the study

Study & Design

• Study Type: Observational
• Study Design: Not specified